Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytosine deaminase (EC 3.5.4.1) is an enzyme that catalyzes the hydrolytic deamination of cytosine to uracil, releasing ammonia. It is found primarily in bacteria and fungi and plays a key role in pyrimidine salvage pathways. It also acts on certain cytosine analogs, most notably converting the prodrug 5-fluorocytosine into the chemotherapeutic agent 5-fluorouracil. Its absence in mammalian cells and presence in pathogens make it a target for antimicrobial drug design and a key component in cancer gene therapy.
Hydrolytic deamination of cytosine to uracil
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytosine Deaminase (CD).